Matches in SemOpenAlex for { <https://semopenalex.org/work/W2903175024> ?p ?o ?g. }
- W2903175024 endingPage "341" @default.
- W2903175024 startingPage "319" @default.
- W2903175024 abstract "The phenomenal rise in cancer over the past few years has made it the second leading cause of death worldwide. Breast cancer constitutes the predominant cancer encountered in women. Triple negative breast cancer (TNBC) is the most notorious form of breast cancer which involves absence of the estrogen, progesterone and human epidermal growth factor receptor (EGFR) on breast cancer cells. It is a real challenge for oncologists owing to the recurrence and metastasis which result in poor prognosis. Conventional therapies employed in treatment of TNBC suffer from issues of poor bioavailability, poor cellular uptake, resistance, and undesirable off-site toxicities. Nanosized delivery systems, herein designated as nanosoldiers can be smartly designed to be equipped with multiple weapons (drugs, genetic materials, photosensitizers, etc.) to fight the battle against recalcitrant TNBC in a myriad of ways such as bioavailability enhancement, targeted uptake by the TNBC cells, on-demand drug delivery at tumour site, combination therapy, multimodal therapy, photodynamic therapy, photothermal therapy, anti-metastatic approaches, theranostics, etc. The versatility of nanosoldiers with respect to their material of composition, their mechanism of drug loading and release, ability to modify in vivo drug disposition, multifunctional characteristics enabling detection, treatment, and monitoring, etc. endows them with incredible potential to destroy the intractable TNBC cells. The focus of the review is to highlight the extraordinary potential of nanocarriers in treatment of TNBC and few challenges which need to be overcome for these nanosoldiers to form a part of the clinical armamentarium of anticancer agents." @default.
- W2903175024 created "2018-12-11" @default.
- W2903175024 creator A5022746808 @default.
- W2903175024 creator A5047607069 @default.
- W2903175024 date "2019-02-01" @default.
- W2903175024 modified "2023-10-16" @default.
- W2903175024 title "Nanosoldiers: A promising strategy to combat triple negative breast cancer" @default.
- W2903175024 cites W1595803348 @default.
- W2903175024 cites W167359183 @default.
- W2903175024 cites W1857266517 @default.
- W2903175024 cites W1895455527 @default.
- W2903175024 cites W1900515166 @default.
- W2903175024 cites W1910713888 @default.
- W2903175024 cites W1934622736 @default.
- W2903175024 cites W1968035235 @default.
- W2903175024 cites W1968820334 @default.
- W2903175024 cites W1972281600 @default.
- W2903175024 cites W1973107158 @default.
- W2903175024 cites W1985420995 @default.
- W2903175024 cites W2004565731 @default.
- W2903175024 cites W2005433498 @default.
- W2903175024 cites W2007152324 @default.
- W2903175024 cites W2010693773 @default.
- W2903175024 cites W2013575967 @default.
- W2903175024 cites W2020832454 @default.
- W2903175024 cites W2027483698 @default.
- W2903175024 cites W2032760352 @default.
- W2903175024 cites W2036565476 @default.
- W2903175024 cites W2037956325 @default.
- W2903175024 cites W2041321390 @default.
- W2903175024 cites W2046267543 @default.
- W2903175024 cites W2050376985 @default.
- W2903175024 cites W2050732886 @default.
- W2903175024 cites W2050914173 @default.
- W2903175024 cites W2060984226 @default.
- W2903175024 cites W2066077563 @default.
- W2903175024 cites W2100173894 @default.
- W2903175024 cites W2106885203 @default.
- W2903175024 cites W2113132576 @default.
- W2903175024 cites W2114931678 @default.
- W2903175024 cites W2116609560 @default.
- W2903175024 cites W2118512977 @default.
- W2903175024 cites W2137621491 @default.
- W2903175024 cites W2143769503 @default.
- W2903175024 cites W2150375936 @default.
- W2903175024 cites W2152942530 @default.
- W2903175024 cites W2156871941 @default.
- W2903175024 cites W2164324841 @default.
- W2903175024 cites W2167243784 @default.
- W2903175024 cites W2185340612 @default.
- W2903175024 cites W2221696309 @default.
- W2903175024 cites W2221837786 @default.
- W2903175024 cites W2224498017 @default.
- W2903175024 cites W2231824866 @default.
- W2903175024 cites W2238317307 @default.
- W2903175024 cites W2255219240 @default.
- W2903175024 cites W2262835844 @default.
- W2903175024 cites W2297007232 @default.
- W2903175024 cites W2309638832 @default.
- W2903175024 cites W2316174168 @default.
- W2903175024 cites W2330848783 @default.
- W2903175024 cites W2331466976 @default.
- W2903175024 cites W2338768170 @default.
- W2903175024 cites W2345094705 @default.
- W2903175024 cites W2346786618 @default.
- W2903175024 cites W2397297897 @default.
- W2903175024 cites W2397798459 @default.
- W2903175024 cites W2401079500 @default.
- W2903175024 cites W2405530013 @default.
- W2903175024 cites W2421853349 @default.
- W2903175024 cites W2469629034 @default.
- W2903175024 cites W2474928846 @default.
- W2903175024 cites W2493010869 @default.
- W2903175024 cites W2518313831 @default.
- W2903175024 cites W2518419687 @default.
- W2903175024 cites W2523763608 @default.
- W2903175024 cites W2529913784 @default.
- W2903175024 cites W2530228098 @default.
- W2903175024 cites W2543690270 @default.
- W2903175024 cites W2547420156 @default.
- W2903175024 cites W2559954820 @default.
- W2903175024 cites W2560836545 @default.
- W2903175024 cites W2561694948 @default.
- W2903175024 cites W2563715196 @default.
- W2903175024 cites W2564285545 @default.
- W2903175024 cites W2578475683 @default.
- W2903175024 cites W2582033605 @default.
- W2903175024 cites W2586322963 @default.
- W2903175024 cites W2589961504 @default.
- W2903175024 cites W2593086409 @default.
- W2903175024 cites W2597228015 @default.
- W2903175024 cites W2602215682 @default.
- W2903175024 cites W2603750384 @default.
- W2903175024 cites W2605935411 @default.
- W2903175024 cites W2605996598 @default.
- W2903175024 cites W2612038942 @default.
- W2903175024 cites W2614719195 @default.
- W2903175024 cites W2626249377 @default.